Baudolino Mussa

Prof. Baudolino Mussa

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2014 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
PCPaolo Cotogni
Paolo Cotogni
CBCristina Barbero
Cristina Barbero
CGCristina Garrino
Cristina Garrino
CDClaudia Degiorgis
Claudia Degiorgis
Baudolino MussaBaudolino Mussa
Baudolino Mussa
MPMauro Pittiruti
Mauro Pittiruti
Purpose Few prospective follow-up studies evaluating the use of peripherally inserted central catheters (PICCs) to deliver chemotherapy and/or home parenteral nutrition (HPN) have focused exclusively on oncology outpatients. The aim of this prospective study was to assess the reliability and the safety of PICCs over a 5-year use in non-hospitalized cancer patients requiring long-term intravenous therapies. Methods Since June 2008, all adult oncology outpatient candidates for PICC insertion were consecutively enrolled and the incidence of catheter-related complications was investigated. The follow-up continued until the PICC removal. Results Two hundred sixty-nine PICCs in 250 patients (98 % with solid malignancies) were studied, for a total of 55,293 catheter days (median dwell time 184 days, range 15–1,384). All patients received HPN and 71 % received chemotherapy during the study period. The incidence of catheter-related bloodstream infections (CRBSIs) was low (0.05 per 1,000 catheter days), PICC-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days). The overall complication rate was 17.5 % (0.85 per 1,000 catheter days) and PICCs were removed because of complications only in 7 % of cases. The main findings of this study were that, if accurately managed, PICCs can be safely used in cancer patients receiving chemotherapy and/or HPN, recording a low incidence of CRBSI, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications. Conclusions Our study suggests that PICCs can be successfully utilized as safe and long-lasting venous access devices in non-hospitalized cancer patients.

14 January 2014 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ABAndrea Baronetto
Andrea Baronetto
PCPaolo Centofanti
Paolo Centofanti
MAMatteo Attisani
Matteo Attisani
DRDavide Ricci
Davide Ricci
Baudolino MussaBaudolino Mussa
Baudolino Mussa
MRMauro Rinaldi
Mauro Rinaldi
Driveline infections are one of the most common and important complications in patients with left ventricular assist device (LVAD). One of the causes favouring the development of this complication is the traumatism of the exit site, which occurs in response to movement of the driveline. In this work, we present a simple and feasible method to immobilize the driveline at the level of the exit site. From April 2013 until November 2013, 6 patients underwent implantation of HeartWare LVAD (HVAD) for an end-stage heart failure. When the patient has begun to mobilize after the implantation of the device, we have combined the use of two components with the aim of securing the driveline to the patient's skin: a StatLock system and a silicone suture. No case of local traumatism and no case of local infection at the driveline were observed during the follow-up. No patient reported pain or swelling at the driveline exit site. All patients were satisfied with their quality-of-life and they do not report any limitations in their daily activities. One of the major long-term complications in patients with LVAD is the development of infections of the exit site of the driveline. The trauma of this skin region promotes the onset and maintenance of an inflammatory process and local infectious. Avoiding excessive mobilization of the driveline is likely to reduce the incidence of infections of the exit site and improve the quality-of-life.

23 February 2004 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SBSergio Bertoglio
Sergio Bertoglio
SSsergio Sandrucci
sergio Sandrucci
PPPierluigi Percivale
Pierluigi Percivale
MGMatteo Goss
Matteo Goss
MGMarco Gipponi
Marco Gipponi
AMAntonio Mussa
Antonio Mussa

1 May 2009 in Lung Cancer
Verified
Journal Article
Closed access
MPMarco Prunotto
Marco Prunotto
MBMartino Bosco
Martino Bosco
LDLorenzo Daniele
Lorenzo Daniele
LMLuigia Macri’
Luigia Macri’
LBLisa Bonello
Lisa Bonello
Anna SapinoAnna Sapino
Anna Sapino

27 May 2021 in Hospital Practice
Verified
Journal Article
Closed access
Baudolino MussaBaudolino Mussa
Baudolino Mussa
FPFulvio Pinelli
Fulvio Pinelli
NRNoemí Cortés Rey
Noemí Cortés Rey
JCJennifer Caguioa
Jennifer Caguioa
FLFredericus Henricus Johannes Van Loon
Fredericus Henricus Johannes Van Loon
DLDidier Lepelletier
Didier Lepelletier
Background: Vascular access by means of intravenous catheters is essential for the safe, effective and cost-efficient delivery of intravenous fluids, antibiotics, nutrition and chemotherapy, but the use of these devices is not without complications. Purpose: A faculty of multidisciplinary European vascular access team (VAT) Leads/Members and experts sought to reframe how the implementation of a VAT could have positive impacts on patients and hospitals. Methods: Interview data from a Faculty of nine VAT Leads/Members and experts from six European countries on the impact of multidisciplinary VATs in modern healthcare were assessed. A literature search was conducted that included Medline®-cited peer-reviewed articles published in the past 10 years in order to identify impact data and post-implementation of a multidisciplinary VAT that support the benefits to patient safety and satisfaction and to hospital efficiencies reported in the interview program. Results: While VATs vary in structure and function, clarity of purpose and supportive training and education are key. Barriers to the implementation of VATs show commonality across countries, such as lack of investment, insufficient training and lack of awareness. Proven markers of VAT success include rapid referrals, improved patient outcomes and improved organizational efficiency. Standardization of outcomes data capture, processing and reporting are key to monitoring performance against baseline. Awareness of the cost of complications arising from inappropriate choice and placement, and poor care and maintenance, of the vascular access device must be raised. Conclusions: The implementation of VATs can positively impact patient safety and satisfaction, improve organizational efficiencies and cost effectiveness, and could create new opportunities for in- and outpatient services, beneficial to both patients and institutions.

17 April 2013 in Minimally Invasive Therapy & Allied Technologies
Verified
Journal Article
Closed access
AAAlberto Arezzo
Alberto Arezzo
SASIMONE AROLFO
SIMONE AROLFO
Massimiliano MistrangeloMassimiliano Mistrangelo
Massimiliano Mistrangelo
Baudolino MussaBaudolino Mussa
Baudolino Mussa
PCPaola Cassoni
Paola Cassoni
MMMario Morino
Mario Morino
Local excision of invasive cancer by transanal endoscopic microsurgery (TEM) entails the risk of lymphnode metastases that obliges to radical surgery. A determination of metastatic lymph-nodes would avoid major surgery in the vast majority of cases. We applied the concept of sentinel lymphnode (SLN) biopsy to suspected invasive rectal cancers treated by TEM. Indocyanine green (ICG) is injected in the submucosa underneath the lesion. The tumor is dissected full-thickness until the perirectal fat. A near infra-red (NIR) optic provides a map of mesorectal lymphatics, on which guide the perirectal fat is dissected and lymph-nodes are excised. The technique was tested in three patients. In all cases the pathologist confirmed presence of lymphnodes in the excised tissue, no case showed metastasis. In all cases final pathology of the rectal neoplasm did not indicate radical surgery. In suspected invasive cancers, SLN mapping could be a useful technique to identify the first lymph node receiving drainage from the tumour, whose accurate pathological examination could predict the status of the remaining nodes and indicate further radical surgery. An ongoing study on a prospective case series will assess sensitivity and negative predictive value of SLN biopsy.